JRJulia D. Rempel

Julia D. Rempel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia D. Rempel has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Alyssa Janke

    Section of Hepatology Department of Medicine University of Manitoba Winnipeg Canada

    1 shared publication
  • C. Krueger

    Section of Hepatology, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada

    1 shared publication
  • Carla Krueger

    Section of Hepatology Department of Medicine University of Manitoba Winnipeg Canada

    1 shared publication
  • Erin Lande

    Section of Transplant Immunology, Department of Medicine, University of Manitoba, Winnipeg, MB, Canada

    1 shared publication
  • G. Minuk

    Section of Hepatology, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada

    1 shared publication
  • G. Y. Minuk

    Section of Hepatology, Department of Internal Medicine, University of Manitoba

    1 shared publication

Latest Publications

  • HCV protein‐induced cytokine predicts treatment outcomes in chronic hepatitis C virus infection

    by Carla Krueger, Mark Collister, Gerald Y. Minuk, Alyssa Janke, Jordyn Lerner, Stephen G. M. Wong, Julia D. Rempel

    Background & Aims: Immune‐mediated processes are thought to influence the efficacy of treatment in chronic hepatitis C virus (HCV) infection. This study evaluated the association of baseline immune responses with the achievement of a sustained viral response (SVR) upon pegylated interferon and ribavirin treatment.Methods: Baseline serum and peripheral blood mononuclear cells (PBMC) cytokine activity was assessed. Metabolic and liver injury parameters were evaluated as underlying factors.Results: Baseline demographics and disease parameters did not differ between the SVR− (n = 14) and SVR+ (n = 25) cohorts except for body mass index (BMI) values and liver injury scores. Baseline circulating TNF‐α levels were three‐fold higher with subsequent treatment failure vs. success (P = 0.124). Baseline peripheral blood mononuclear cells (PBMC, n = 25) were cultured with HCV core and non‐structural (NS)3 proteins. Core (P = 0.0003) and NS3 (P = 0.018) induced greater TNF‐α production within the SVR−, compared with the SVR+, cohorts. Similar findings were noted for interleukin (IL)‐1β and IL‐10 synthesis. Furthermore, HCV core‐induced TNF‐α synthesis correlated with patient BMI values (r = 0.489, P = 0.015). Core (r = 0.432, P = 0.065) and NS3 (r = 0.530, P = 0.020)‐induced TNF‐α displayed a positive relationship with serum adiponectin concentrations. In addition, lipopolysaccharide stimulated cytokine synthesis associated with BMI and adiponectin levels. Although unable to predict treatment outcomes, NS3‐induced IL‐6 synthesis and serum leptin concentrations corresponded to liver injury scores.Conclusion: An enhanced PBMC susceptibility to core and NS3‐induced TNF‐α synthesis at baseline was associated with treatment failure. This phenomenon appeared to involve the interaction of virally generated TNF‐α activity and metabolic disease. In contrast, IL‐6 activity and leptin levels may indicate liver damage.

  • The potential influence of KIR cluster profiles on disease patterns of Canadian Aboriginals and other indigenous peoples of the Americas

    by Julia D Rempel, Kim Hawkins, Erin Lande, Peter Nickerson

    Genetic differences in immune regulators influence disease resistance and susceptibility patterns. There are major health discrepancies in immune-mediated diseases between Caucasians and Canadian Aboriginal people, as well as with other indigenous people of the Americas. Environmental factors offer a limited explanation as Aboriginal people also demonstrate a rare resistance to chronic hepatitis C virus infection. Killer immunoglobulin-like receptors (KIRs) are known modulators of viral responses and autoimmune diseases. The possibility that variation in KIR cluster profiles contribute to the health outcomes of Aboriginal people was evaluated with Canadian Caucasian (n=93, population controls) and Aboriginal (n=86) individuals. Relative to Caucasians, the Aboriginal KIR cluster displayed a greater immune activating phenotype associated with genes of the B haplotype situated within the telomeric region. In conjunction, there was a decrease in the genes of the B haplotype from the centromeric region. Caucasian and Aboriginal cohorts further demonstrated distinct genotype and haplotype relationships enforcing the disconnect between the B haplotype centromeric and telomeric regions within the Aboriginal population. Moreover, Caucasian KIR cluster patterns reflected studies of Caucasians globally, as well as Asians. In contrast, the unique pattern of the Canadian Aboriginal cohort mirrored the phenotype of other indigenous peoples of the Americas, but not that of Caucasians or Asians. Taken together, these data suggest that historically indigenous peoples of the Americas were subject to immune selection processes that could be influencing the current disease resistance and susceptibility patterns of their descendents.


  • Persistent pro‐inflammatory cytokines following the initiation of pegylated IFN therapy in hepatitis C infection is associated with treatment‐induced depression

    by C. Krueger, K. Hawkins, S. Wong, M. W. Enns, G. Minuk, J. D. Rempel

    Pegylated interferon (IFN), the basis for chronic hepatitis C virus (HCV) treatment, causes depression in 30-40% of patients. The potential for cytokine mRNA patterns from baseline into early treatment to associate with the onset of treatment-induced depression (TID) was examined. Depression was measured by the Beck Depression Inventory at baseline and weeks 2, 4, 8 and 12 of treatment (n = 38). At baseline and weeks 2 and 4, peripheral blood mononuclear cell (PMBC, n = 28), isolated ex vivo, were examined for tumour neurosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 mRNA expression. In patients that developed treatment-induced depression, pro-inflammatory TNF-alpha mRNA levels from baseline into week 4 of therapy remained constant (1.1-fold increase); whereas IL-1beta transcripts decreased 3.5 fold. However, corresponding TNF-alpha (3-fold, P < 0.05) and IL-1beta (7.5-fold) transcript expression diminished to a greater extent in the absence of TID. Changes in TNF-alpha mRNA values correlated to the average change in BDI scores over the 12 weeks (r = 0.56, P < 0.05). Concomitantly, anti-inflammatory IL-10 transcript levels decreased in (TID), relative to increased expression in the absence of TID (P < 0.05). The potential influence of IL-10 was observed upon calculation of individual pro- verses anti-inflammatory mRNA ratios. Stable in the presence of depression, TNF-alpha/IL-10 and IL-1beta/IL-10 mRNA ratios declined significantly over time in its absence (P < 0.05). This study suggests that in chronic HCV infection, upon pegylated IFN administration persistent pro-inflammatory cytokine MRNA expression associates with TID. In contrast, therapeutic activation of mechanisms that decrease pro-inflammatory immunity may protect against depression during therapy.


  • The influence of North American Aboriginal ethnicity on pro‐inflammatory and anti‐inflammatory cytokine responses to IFN‐alpha

    by J. D. Rempel, K. B. Aborsangaya, M. P. Alphonse, G. Y. Minuk

    Summary. North American Aboriginals have an enhanced propensity to clear HCV infection. Interferon (IFN)‐α is a critical agent in the clearance of hepatitis C virus (HCV) and other viruses; therefore the influence of Aboriginal ethnicity on IFN‐α responses was investigated in healthy Caucasian population control and Aboriginal cohorts. Cohort peripheral blood mononuclear cells produced similar levels of IFN‐α upon culture with reovirus, an innocuous virus capable of triggering IFN‐α synthesis. In addition, similar IFN‐γ synthesis was observed in the presence IFN‐α or reovirus. In contrast, Caucasian supernatants exhibited greater IL‐10 levels (P < 0.005), contributing to the overall cytokine balance as assessed by IFN‐γ/IL‐10 ratios being consistently elevated in the Aboriginal cohort. The potential of HCV proteins to alter IFN‐α cytokine induction was also investigated. Although there was some indication that HCV proteins might increase IFN‐α induced IL‐10 synthesis in Caucasians and conversely, IFN‐γ synthesis in Aboriginals, the addition of HCV proteins did not influence IFN‐γ/IL‐10 ratios. Finally, signal transducer and activator of transcription (STAT) 3 nuclear translocation was examined by western blot because it is a required intermediate in IFN‐α induced IL‐10 synthesis. Supporting the differential IL‐10 production, IFN‐α and core synergistically enhanced STAT3 nuclear translocation in Caucasian (P < 0.05); whereas, nuclear translocation of STAT3 remained unchanged in Aboriginal cells. Taken together, these findings suggest that ethnicity may influence certain responses to IFN‐α, possibly even in the presence of viral agents. These differences could impact early immune events allowing for enhanced viral clearance in Aboriginal populations.